Semi-Annual Consolidated Statement Of Comprehensive Income

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7595304

Concept 2022-04-01 to
2022-06-30
2021-04-01 to
2021-06-30
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
1,323,000,000 JPY
1,098,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
323,000,000 JPY
-35,000,000 JPY
Remeasurements of defined benefit plans, net of tax
6,000,000 JPY
7,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
139,000,000 JPY
-84,000,000 JPY
Other comprehensive income
469,000,000 JPY
-112,000,000 JPY
Comprehensive income
1,792,000,000 JPY
986,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
1,792,000,000 JPY
986,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.